Sichuan Kelun Pharmaceutical (002422.SZ): Rosuvastatin Patch Receives Drug Registration Approval
Kailun Pharmaceutical (002422.SZ) announced that the company's chemical drug "Rosuvastatin Patch" has recently received national drug approval.
Sichuan Kelun Pharmaceutical (002422.SZ) announced that its chemical drug "Rotigotine Patch" recently received drug registration approval from the National Medical Products Administration. The Rotigotine Patch was developed by UCB Pharma, approved by the EU in 2006, approved for import in China in 2018, and used for monotherapy of early-stage idiopathic Parkinson's disease symptoms and signs, or in combination with levodopa for various stages of the disease.
Related Articles
On October 17th, JIUMAOJIU (09922) spent 1.0013 million Hong Kong dollars to repurchase 49.1 thousand shares.
On October 17th, ANTON OILFIELD (03337) spent approximately 5 million Hong Kong dollars to buy back 449.2 million shares.
Zkteco Co., Ltd. (301330.SZ) plans to acquire 55% of Longzhiyuan's equity to enrich its product array.
On October 17th, JIUMAOJIU (09922) spent 1.0013 million Hong Kong dollars to repurchase 49.1 thousand shares.
On October 17th, ANTON OILFIELD (03337) spent approximately 5 million Hong Kong dollars to buy back 449.2 million shares.
Zkteco Co., Ltd. (301330.SZ) plans to acquire 55% of Longzhiyuan's equity to enrich its product array.
RECOMMEND
